An Evaluation of the Safety and Pharmacokinetics of Tavaborole Topical Solution for the Treatment of Fungal Disease of the Toenail in Children and Adolescents

PHASE4CompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

October 22, 2015

Primary Completion Date

July 27, 2017

Study Completion Date

July 27, 2017

Conditions
OnychomycosisTinea Unguium
Interventions
DRUG

Tavaborole 5% Topical Solution

topical solution for application to toenails

Trial Locations (12)

10155

Skin Specialty Dermatology, New York

11203

University Hospital, SUNY Downstate Medical Center, Brooklyn

20016

MedStar Health Research Institute - MedStar Georgetown University Hospital, Washington D.C.

22015

PI Coor Clinical Research, LLC, Burke

33143

Doctors Research Network, South Miami

77055

West Houston Clinical Research Services LLC, Houston

78218

Texas Dermatology and Laser Specialists, San Antonio

84088

Jordan Valley Dermatology Center, West Jordan

93637

Madera Family Medical Group, Madera

94304

Stanford University School of Medicine, Palo Alto

97030

Cyn3rgy Research, Gresham

97210

Oregon Dermatology & Research Center, Portland

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY